International Journal of Global Business and Competitiveness Бизнес и менеджмент

Corporate Risk Management by Indian Pharmaceutical Companies: A Comprehensive Literature Review

Parmar, Jaykumar G., Dalvadi, Yagnesh M.
Springer Nature · 2026-09-01 · DOI 10.1007/s42943-026-00159-8

Аннотация

As a global pharmaceutical powerhouse, India’s generic drug sector faces multifaceted risks that significantly impact its international competitiveness. This study maps the intellectual structure of corporate risk management (CRM) to evaluate its role in sustaining global market advantage. Employing a quantitative bibliometric methodology guided by the PRISMA framework, 47 peer-reviewed articles were extracted from the Lens.org database (2000–2026). VOSviewer keyword co-occurrence mapping reveals four primary risk clusters dictating sector competitiveness: regulatory compliance, supply chain vulnerabilities, operational quality, and financial/strategic risks. The findings demonstrate a temporal shift in the literature from traditional financial hedging toward holistic supply chain resilience and technology-driven CRM. Crucially, the study posits that effective CRM functions as a critical enabler of international competitiveness, enabling firms to navigate regulatory scrutiny and macroeconomic shocks. The paper provides evidence-based strategies for pharmaceutical practitioners to integrate Quality Risk Management (QRM) with Enterprise Risk Management (ERM), thereby enhancing corporate resilience and comparative advantage in the healthcare eco-system.

Читать у издателя →